Treating Cancer with Radiopharmaceuticals at Missouri Cancer Associates
As part of our commitment to offering advanced, personalized cancer care, Missouri Cancer Associates provides state-of-the-art radiopharmaceutical treatments. These groundbreaking therapies target cancer cells with high precision, allowing us to address the disease at the cellular level while minimizing impact on healthy tissue.
Understanding Radiopharmaceuticals
Radiopharmaceuticals represent a major advancement in cancer treatment, delivering radiation directly to cancer cells through various methods, such as pill, injection, or infusion. This approach offers a more targeted alternative to traditional radiation therapy, which typically relies on external machines or radioactive seeds.
Radiopharmaceutical therapy is a powerful treatment option for targeting cancers that have spread to specific areas within the body. It is especially beneficial in treating metastatic cancers, including advanced prostate cancer that has spread to the bones.
This therapy is also effective for targeting specific areas where traditional treatments may not reach, allowing physicians to treat cancers in areas such as the liver, lymph nodes, and other soft tissues. By precisely delivering radiation to these targeted sites, radiopharmaceuticals offer a promising approach to managing cancer in complex or widespread areas while minimizing effects on surrounding healthy tissue.
Diagnostic Radiopharmaceuticals
Diagnostic radiopharmaceuticals are administered prior to a positron emission tomography (PET) scan. Once in the bloodstream, they attach to cancer-specific proteins, providing precise information about the location and spread of cancer. At Missouri Cancer Associates, we offer Pylarify®, a diagnostic radiopharmaceutical that helps physicians make informed treatment decisions.
Therapeutic Radiopharmaceuticals
Therapeutic radiopharmaceuticals work by binding to specific receptors on cancer cells, delivering targeted radiation that destroys or inhibits the growth of these cells while sparing nearby healthy tissue. Our therapeutic offerings include Pluvicto® and Xofigo®, which are designed for patients with advanced prostate cancer and other eligible conditions.
Benefits of Radiopharmaceutical Treatment
Radiopharmaceuticals offer significant benefits, including:
- Precision Treatment: Targeted delivery reduces effects on healthy tissues.
- Life-Extending Benefits: Advanced treatments can improve survival rates for eligible patients.
- Reduced Side Effects: Patients often experience fewer side effects compared to conventional treatments.
- Symptom Relief: Many patients find relief from symptoms associated with cancer progression.
Missouri Cancer Associates is proud to offer these advanced options, helping patients with advanced prostate cancer and other qualifying conditions benefit from the latest in radiopharmaceutical therapy.
Frequently Asked Questions About Radiopharmaceutical Treatments
What is Pylarify® and how is it used?
Pylarify® is a diagnostic radiopharmaceutical used in PET scans to detect prostate-specific membrane antigens (PSMA) in patients with prostate cancer. After injection, Pylarify® travels through the bloodstream, binding to PSMA proteins on prostate cancer cells. This allows for high-resolution imaging to locate cancerous areas and assess the spread of the disease, helping doctors develop a precise treatment plan.
What types of cancer can be treated with radiopharmaceuticals?
Radiopharmaceuticals are effective in treating various cancers, especially those that have metastasized or spread to other areas of the body. Commonly treated cancers include advanced prostate cancer, neuroendocrine tumors, and other cancers that have affected the bones, liver, and lymph nodes.
How are radiopharmaceuticals administered?
Radiopharmaceuticals can be delivered in several ways, depending on the type and purpose of the treatment. Diagnostic radiopharmaceuticals, like Pylarify®, are generally injected prior to imaging, while therapeutic radiopharmaceuticals are administered via pill, injection, or infusion. Your healthcare provider will determine the best method based on the specific treatment plan.
How does radiopharmaceutical therapy differ from traditional radiation therapy?
Unlike traditional radiation therapy, which typically uses external beams or radioactive seeds implanted near the cancer site, radiopharmaceutical therapy delivers radiation directly to cancer cells through a targeted approach. This minimizes radiation exposure to surrounding healthy tissues, potentially reducing side effects and enhancing treatment precision.
What are some examples of therapeutic radiopharmaceuticals?
Examples of therapeutic radiopharmaceuticals include Pluvicto® and Xofigo®. Pluvicto® targets advanced prostate cancer by binding to PSMA on cancer cells, while Xofigo® targets cancer that has spread to the bones. Both treatments work by delivering radiation specifically to cancer cells, either destroying them or inhibiting their growth.
What are the benefits of radiopharmaceutical treatment?
Radiopharmaceutical treatment offers precision targeting, which can extend life expectancy for eligible patients, reduce side effects compared to traditional radiation, and provide symptom relief. It is a promising option for managing cancer in areas that may be difficult to reach with other therapies.
Are there side effects associated with radiopharmaceutical therapy?
While radiopharmaceuticals are designed to target cancer cells selectively, some patients may experience side effects such as fatigue, nausea, or localized pain. Your healthcare provider will discuss potential side effects and work to manage them as part of your treatment plan.
Who is eligible for radiopharmaceutical treatment?
Eligibility depends on the type, stage, and location of the cancer, as well as individual health factors. Patients with advanced prostate cancer or cancers that have metastasized to specific areas, like the bones or lymph nodes, are often candidates for radiopharmaceutical therapy. A consultation with your oncology team will help determine if this treatment is suitable for you.
How do I know if radiopharmaceutical therapy is right for me?
Your oncologist will evaluate your specific cancer type, stage, and medical history to determine if radiopharmaceutical therapy is a good option for you. They will explain the benefits, potential risks, and expected outcomes, so you can make an informed decision about your treatment plan.
Take the Next Step in Precision Cancer Treatment
If you or a loved one has been diagnosed with cancer and want to explore cutting-edge, targeted treatment options, Missouri Cancer Associates is here to help. Our radiopharmaceutical therapies offer a personalized approach designed to target cancer cells directly, providing advanced care while minimizing effects on healthy tissue.
Contact us today to learn more about radiopharmaceutical treatment options and see if this innovative therapy could be part of your treatment plan.
Karen Singleton decided to schedule a routine mammogram. As it turned out, that simple, preventive measure in March 2018 ended up saving her life. Because of her early diagnosis and the location of her tumor, Karen’s treatment plan included a lumpectomy , followed by internal radiation — also called brachytherapy or seed implantation. Read Karen’s survivor story.